Senior Manager, Clinical Scientist, Hematology
Regeneron Pharmaceuticals
Summary
We are seeking a Senior Manager, Hematology Clinical Sciences to join our Clinical Sciences team, supporting our hematology clinical programs in a matrixed, cross-functional environment. In this role, you will contribute to the planning, execution, and data interpretation of clinical studies across early and late phase development, helping ensure the integrity of study data and the safety of patients. You will collaborate closely with Medical Directors and cross-functional partners as a member of the Clinical Study Team and Global Clinical SubTeam.
Job description
Discover your role
- Partner with Medical Directors to provide the scientific expertise needed to design and deliver clinical studies and programs
- Contribute to program team meetings, advisory boards, steering committees, and data/safety monitoring meetings
- Build and maintain understanding of the disease area, drug candidate, mechanism of action, and drug landscape
- Assist with developing the Expanded Synopsis and author or review clinical sections of protocols, amendments, and study reports
- Author or review medical monitoring plans, SAPs, and informed consents, and support regulatory document development
- Perform clinical data review and safety monitoring, promoting consistent review practices across assigned studies
- Identify critical risks and recommend mitigations, while maintaining compliance with FDA, EMEA, ICH, and GCP guidelines
- Influence within and across teams with clear, concise communication and creative problem-solving
This role requires
- Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc) and 8+ years of pharmaceutical clinical drug development experience (other levels considered depending on experience)
- Proven knowledge of the drug development process, Good Clinical Practice, study design, clinical research methodology, and medical writing
- Strong analytical, presentation, interpersonal, and problem-solving skills
- Significant experience working cross-functionally, with strong organizational awareness
- Preferred: Proven track record of clinical trial process improvements
Requirements
- Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc)
- 8+ years of pharmaceutical clinical drug development experience
- Proven knowledge of the drug development process
- Good Clinical Practice knowledge
- Study design knowledge
- Clinical research methodology knowledge
- Medical writing knowledge
- Strong analytical skills
- Strong presentation skills
- Strong interpersonal skills
- Strong problem-solving skills
- Significant experience working cross-functionally
- Strong organizational awareness
- Preferred: Proven track record of clinical trial process improvements
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.